DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,705 | +10.9% | 23,135 | -3.1% | 0.01% | +16.7% |
| Q2 2023 | $308,000 | -15.6% | 23,865 | -35.8% | 0.01% | -20.0% |
| Q1 2023 | $365,000 | -11.0% | 37,191 | -3.4% | 0.02% | -6.2% |
| Q4 2022 | $410,000 | +23.1% | 38,511 | +20.7% | 0.02% | +14.3% |
| Q3 2022 | $333,000 | -41.6% | 31,913 | -29.5% | 0.01% | -39.1% |
| Q2 2022 | $570,000 | +11.8% | 45,290 | -3.7% | 0.02% | +35.3% |
| Q1 2022 | $510,000 | +722.6% | 47,025 | +229.8% | 0.02% | +750.0% |
| Q3 2020 | $62,000 | -64.4% | 14,258 | -27.3% | 0.00% | -71.4% |
| Q2 2020 | $174,000 | – | 19,618 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |